A brand new KFF evaluation examines the variety of enrollees within the employer-sponsored insurance coverage market who use a number of of the ten medication chosen for Medicare Half D value negotiations. Among the many 167 million individuals with employer-sponsored insurance coverage in 2022, 3.4 million used at the very least one of many 10 medication.
The evaluation is obtainable on the Peterson-KFF Well being System Tracker, a web-based data hub devoted to monitoring and assessing the efficiency of the U.S. well being system.
